| Literature DB >> 30733801 |
Amal Aboud Alasmari1, Anadel Hassan Hakeem1, Fatemah Saleh Bin Saleh1, Shahad Yousef Alsaigh1, Waleed Al Ajroush2, Laila Ali Layqah3, Salim Alawi Baharoon4.
Abstract
Introduction. Skin manifestations are common in hematology ward patients and can result from infection, malignancy, or chemotherapy. The purpose of this study was to identify the most common dermatological problems encountered in the adult hematology ward at King Abdullah Specialist Children Hospital (KASCH). Methods. This was retrospective chart review of 78 dermatology consultations based on electronic health records for all inpatients in hematology wards at KASCH between January 2016 and December 2017. Data were presented as mean ± SD for continuous variables. Results. During the study period, a total of 1391 inpatients were referred to the dermatology department. A total of 403 (29.0%) referrals were from the internal medicine department and 78 (5.6%) were from the hematology department, six of which were rejected by the dermatology department. Almost all requests for referral were managed on the same or the next day with only two requests after 3 days. There were more female (n = 40; 51.3%) than male patients (n = 38; 48.7%) and the average age ± SD was 40.7 ± 19.8 years. Patients were diagnosed with a diverse range of hematological diseases. A total of 27 (35.1%) patients were diagnosed with acute myeloid leukemia. Overall, 98 differential diagnoses were made by dermatologists with only 26 being confirmed by skin biopsy. Eight (30.8%) patients were diagnosed with graft versus host disease confirmed by skin biopsy. The diagnoses were changed in 12 cases after skin biopsy. Several types of dermatitis were diagnosed in hematology ward patients including stasis dermatitis and contact dermatitis. The source of infection was not specified in most cases and the infection was treated empirically. Conclusion. Various dermatological disorders and cutaneous manifestations are observed in hematology inpatients with morbilliform drug eruption and graft versus host disease being the most common.Entities:
Year: 2019 PMID: 30733801 PMCID: PMC6348816 DOI: 10.1155/2019/9891270
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Underlying hematological diagnoses.
|
|
|
|---|---|
| Acute myeloid leukemia | 27 (35.1) |
| Acute lymphoblastic leukemia | 14 (18.2) |
| Hodgkin lymphoma | 8 (10.4) |
| Non-Hodgkin lymphoma | 5 (6.5) |
| Iron deficiency Anemia | 5 (6.5) |
| Non-Langerhans cell histiocytosis | 5 (6.5) |
| Multiple myeloma | 4 (5.2) |
| Chronic lymphoblastic leukemia | 2 (2.6) |
| Langerhans cell histiocytosis | 2 (2.6) |
| Hairy cell leukemia | 2 (2.6) |
| Sickle cell anemia | 1 (1.3) |
| Pancytopenia | 1 (1.3) |
| Others | 1 (1.3) |
Differential diagnoses made by dermatologists.
|
|
|
|---|---|
| Morbilliform drug eruption | 17 (17.3) |
| Infection | 13 (13.3) |
| Graft versus host disease | 8 (8.2) |
| Toxic erythema of chemotherapy / Neutrophilic eccrine hidradenitis | 6 (6.2) |
| Petechiae and purpura | 5 (5.1) |
| Varicella/herpes zoster | 4 (4.1) |
| Exanthem | 4 (4.1) |
| Leukemia cutis | 3 (3.1) |
| Sweet syndrome | 3 (3.1) |
| Unknown | 2 (2.0) |
| Cellulitis | 2 (2.0) |
| Intertrigo | 2 (2.0) |
| Furunculosis | 2 (2.0) |
| Vasculitis | 2 (2.0) |
| Oral candidiasis | 1 (1.0) |
| Ecthyma gangrenosum | 1 (1.0) |
| Bullous impetigo | 1 (1.0) |
| Kaposi sarcoma | 1 (1.0) |
| Prurigo Simplex | 1 (1.0) |
| Acne | 1 (1.0) |
| Neurofibromatosis | 1 (1.0) |
| Ecchymosis | 1 (1.0) |
| Ecthyma | 1 (1.0) |
| Pseudomonas ulcer | 1 (1.0) |
| CMV | 1 (1.0) |
| Lichen Simplex Chronicus | 1 (1.0) |
| Mycosis fungoides | 1 (1.0) |
| Lichen planus pigmentosus | 1 (1.0) |
| Ashy dermatosis | 1 (1.0) |
| Seborrheic keratosis | 1 (1.0) |
| Erythroderma | 1 (1.0) |
| Pressure ulcer | 1 (1.0) |
| Stasis dermatitis | 1 (1.0) |
| Folliculitis | 1 (1.0) |
| Radiation dermatitis | 1 (1.0) |
| Contact dermatitis | 1 (1.0) |
| DRESS | 1 (1.0) |
| Erythema nodosum | 1 (1.0) |
| Abscess | 1 (1.0) |
∗ Cytomegalovirus; ∗∗ drug reaction with eosinophilia and systemic symptoms.
Dermatological diseases diagnosed in hematology inpatients confirmed by skin biopsy.
|
|
|
|---|---|
| Graft versus host disease | 8 (30.8) |
| Morbilliform drug eruption | 3 (11.5) |
| Unknown | 3 (11.5) |
| Mycosis fungoides | 2 (7.7) |
| Infection | 2 (7.7) |
| Leukemia cutis | 1 (3.8) |
| Varicella ∖ herpes zoster | 1 (3.8) |
| Seborrheic keratosis | 1 (3.8) |
| Histiocytic infiltrate with histiocytic vasculitis | 1 (3.8) |
| Hyperpigmentation | 1 (3.8) |
| Morphea | 1 (3.8) |
| Sweet syndrome | 1 (3.8) |
| Vasculitis | 1 (3.8) |